The diagnostics of gynecological diseases has seen tremendous growth in the recent years owing to the disposal of imaging systems like ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans. The gynecological devices market in the US was worth US$14.9 billion in 2014 and is predictable to touch US$22.6 billion in 2023, growing at a CAGR of 4.8% from 2015 to 2023.
As per the UN, the worldwide female populace made for more than 3.64 billion in 2015. Every female goes to a gynecologist more or less one time in her lifespan either for pregnancy or other problems associated with menstrual cycle. The increasing number of patients is prospective to drive market growth in the coming years. In addition, healthcare agencies are now endorsing routine examinations for primary cancer recognition and other gynecological disorders.
Additionally, the launch of consumer-friendly and cutting-edge products has amplified the acceptance of surgical processes such as ablation, laparoscopy, endoscopy, and female sterilization. The availability of these scientifically innovative products together with intensifying acceptance of surgical techniques is piloting the global gynecological devices market towards undergoing instantaneous growth.
The global gynecological devices market is also propeleld by the altering lifestyle and the upsurge in the earnings of people in the emerging nations. There has been an escalation in the pervasiveness of ailments such as menorrhagia, uterine fibroids, and cervical cancers, which consecutively lifts the world-wide gynecological devices market.
Gynecological devices market is in embryonic state owing to surge in aging female population, and intensification in occurrence of diseases linked to female reproductive systems. In addition, elements, for example, upturn in alertness quotient and sexually transmitted diseases in womenfolk also donate to the market growth. Furthermore, launch of new devices in the market causes negligible uneasiness, enhanced efficacy, and growth in healthcare outlay, and approving reimbursement guidelines contribute towards the market growth of gynecological devices. Nonetheless, aspects such as postponement in approvals from governing authorities and strict government guidelines hamper the market growth.
The diagnostic imaging system is anticipated to grow at a CAGR of 5.8% during the period from 2015 to 2023 due to technical invention. Surgical devices made for the biggest share owing to the exclusivity in their uses and by profits. The sterilization and contraceptive devices lead the market and are estimated to retain its supremacy all over the period from 2015 to 2023.
Read more on Medical Equipment on: